Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Procedural Pain in Palliative Care
NCT03151863Phase 3Terminated
- Start
- Nov 2018
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in procedural pain. Started Nov 2018; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03151863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151863.